Lv6
2218 积分 2024-08-08 加入
图奇吃悠米
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
17天前
已完结
Efficacy and Safety of The Albumin‐Bound Paclitaxel Combined with Anti‐PD‐1 Antibody in Pancreatic Ductal Adenocarcinoma
17天前
已完结
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIB trial
28天前
已完结
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined With Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
1个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
2个月前
已完结
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial
2个月前
已完结
Adjuvant immunotherapy versus observation in patients with lymph node-positive status after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a prospective, single-center, controlled phase II study
2个月前
已完结
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
2个月前
已完结
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
3个月前
已完结
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
3个月前
已完结
皖公网安备34019202002308
